GlassScriptPhysician profile
Chiragkumar Patel
NPI 1144968140
$3,109.33
in general payments reported to CMS, 2019-2025
11 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $569 · 2023: $1,891 · 2024: $278 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,349 · Food and Beverage: $954 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,348.84 |
| Food and Beverage | $954.43 |
| Education | $237.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,895.28 | 2022-2023 | Da Vinci Surgical System, Davinci Xi |
| Novo Nordisk INC | $263.45 | 2023-2024 | Wegovy |
| Medical Device Business Services, INC. | $224.69 | 2023 | |
| Stryker Corporation | $216.87 | 2022-2025 | Pangea, Gamma, Pelvis II |
| Lilly USA, LLC | $158.62 | 2024-2025 | Zepbound |
| Tela Bio, INC. | $139.86 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intra-Sana Laboratories | $69.20 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Davol INC. | $40.62 | 2022-2023 | Arista Ah Flexitip |
| Reshape Lifesciences INC. | $38.88 | 2022-2023 | |
| Medtronic, INC. | $36.15 | 2022 | |
| Ethicon US, LLC | $25.71 | 2025 | Stratafix, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chiragkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.